Is Phathom Pharmaceuticals, Inc. (PHAT) a Buy, Sell, or Hold?
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
$10.7439 USD
-$0.29 (-2.64%)
- Volume
- 602.7K
- Average Volume
- 1.24M
- Market Capitalization
- $856.89M
- P/E Ratio
- -5.07
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $18.31
- Year Low
- $7.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.21
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-53.3% DOWNSIDE
$23.00 Price Target
UPSIDE/DOWNSIDE HIGH
-61.6% DOWNSIDE
$28.00 Price Target High
UPSIDE/DOWNSIDE LOW
-40.3% DOWNSIDE
$18.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Barclays | Jenna Davidner | $18 | $10.58 | 2026-03-27 04:55 AM | 70.1% |
| Stifel Nicolaus | Annabel Samimy | $28 | $13.6221 | 2026-02-26 12:51 PM | 105.5% |
| Raymond James | Martin Auster | $28 | $14.56 | 2025-12-11 04:10 PM | 92.3% |
| Barclays | Jenna Davidner | $16 | $14.9 | 2025-12-08 04:27 PM | 7.4% |
| Craig-Hallum | Chase Knickerbocker | $22 | $13.76 | 2025-10-31 09:26 AM | 59.9% |
| Guggenheim | Yatin Suneja | $20 | $13.31 | 2025-10-30 12:03 PM | 50.3% |
| Goldman Sachs | Paul Choi | $12 | $11.75 | 2024-08-08 12:17 PM | 2.1% |
| H.C. Wainwright | Matthew Caufield | $28 | $10.945 | 2024-07-19 06:02 AM | 155.8% |